Загрузка...
Sitagliptin ameliorates high glucose-induced cell proliferation and expression of the extracellular matrix in glomerular mesangial cells
Diabetic nephropathy (DN) is one of the most important causes that leads to end-stage renal disease and the efficacy of strategies currently available for the prevention of DN remains unsatisfactory. Sitagliptin (SIT), which is a dipeptidyl peptidase-4 inhibitor, exhibited a modest beneficial effect...
Сохранить в:
| Опубликовано в: : | Exp Ther Med |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
D.A. Spandidos
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5639317/ https://ncbi.nlm.nih.gov/pubmed/29042993 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2017.5002 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|